AMGN - Amgen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Amgen Inc.

One Amgen Center Drive
Thousand Oaks, CA 91320
United States
805-447-1000
http://www.amgen.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees21,500

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert A. BradwayChairman, CEO & Pres6.06MN/A1963
Mr. David W. MelineExec. VP & CFO2.86MN/A1957
Mr. Jonathan P. GrahamSr. VP, Gen. Counsel & Sec.2.55MN/A1961
Dr. David M. Reese M.D.Exec. VP of R&D2.04M164.3k1963
Mr. Murdo GordonExec. VP of Global Commercial Operations4.18MN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; and DaVita Inc., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Corporate Governance

Amgen Inc.’s ISS Governance QualityScore as of October 4, 2019 is 2. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.